ArticleMolecular oncology2022

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients.

Daan C L Vessies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.